Tyra Biosciences, Inc. (TYRA) SEC Filings — 2024
26 SEC filings for Tyra Biosciences, Inc. (TYRA) in 2024.
Filings
- Boxer Capital Amends Tyra Biosciences Stake Filing — SC 13D/A · Dec 6, 2024
- Boxer Capital Amends Tyra Biosciences Stake — SC 13D/A · Nov 19, 2024
- Tyra Biosciences, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Tyra Biosciences, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- RA Capital Amends Tyra Biosciences Stake — SC 13D/A · Nov 13, 2024
- Tyra Biosciences, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Tyra Biosciences Files Q3 2024 10-Q — 10-Q · Nov 7, 2024
- Tyra Biosciences Files 8-K Report — 8-K · Oct 28, 2024
- Tyra Biosciences Appoints New CMO, Adds Directors — 8-K · Oct 25, 2024
- RA Capital Amends Tyra Biosciences Stake — SC 13D/A · Oct 22, 2024
- Boxer Capital Amends Tyra Biosciences Stake — SC 13D/A · Oct 22, 2024
- Tyra Biosciences Reports Unregistered Equity Sales — 8-K · Oct 18, 2024
- Boxer Asset Management amends Tyra Biosciences stake — SC 13D/A · Oct 15, 2024
- Tyra Biosciences Files Q2 2024 10-Q Report — 10-Q · Aug 7, 2024
- Tyra Biosciences Holds Annual Meeting, Elects Directors — 8-K · May 31, 2024
- Tyra Biosciences, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- Tyra Biosciences Appoints New CMO, Adopts Equity Plan — 8-K · May 7, 2024
- Tyra Biosciences, Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 18, 2024
- Tyra Biosciences Files 2023 Annual Report on Form 10-K — 10-K · Mar 19, 2024
- Tyra Biosciences, Inc. SC 13G/A Filing — SC 13G/A · Mar 11, 2024
- Tyra Biosciences, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- FMR LLC & Abigail Johnson Trim TYRA Stake to 6.43% — SC 13G/A · Feb 9, 2024
- Boxer Capital Amends Tyra Biosciences Stake, Ownership Group Detailed — SC 13D/A · Feb 8, 2024
- RA Capital Amends Tyra Biosciences Stake, Kolchinsky Joins Group — SC 13D/A · Feb 6, 2024
- Tyra Biosciences Sells Unregistered Equity, Secures New Funding — 8-K · Feb 5, 2024
- TYRA Biosciences Files 8-K for 'Other Event', Confirms Emerging Growth Status — 8-K · Feb 1, 2024